China Universal Asset Management »

Tourmaline Bio shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $113k 4.9k 22.88
2023-12-31 $62k 2.4k 26.30

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Tourmaline Bio

Blue Owl Capital Holdings
Jennison Associates
QVT Financial
Vanguard Group
Braidwell
venBio Select Advisor
Dr. Jeffrey R. Jay, M.D.
Qiming U.S. Ventures Management
Vivo Capital
Nantahala Capital Management
Balyasny Asset Management
Logos Global Management
Susquehanna International
Artal Group
AlphaCentric Advisors

View all funds holding Tourmaline Bio